Asthma is a ______ disease
Variable
The SYGMA trials found a comparable risk of severe exacerbations with ____% lower inhaled corticosteroid load versus the traditional approach.
a) 75%
b) 50%
c) 25%
d) 60%
a) 75%
In Declare, Forxiga reduces hospitalization of Heart Failure by
a) 12%
b) 18%
c) 22%
d) 27%
d) 27% (majority of patients in the trial are primary prevention)
How many years does it take for 68% of patients with Type 2 Diabetes to show signs of left ventricular dysfunction?
a) 5 years
b) 8 years
c) 10 years
d) 15 years
a) 5 years. Cardiac changes occur very early in T2D patients - highlighting the importance of using a drug with proven cardiorenal protection in primary prevention patients
Asthma patients are at risk of severe, potentially life threatening exacerbations, regardless of ________ _________
disease severity
How long before an asthma attack are patients increasing their SABA use?
2 weeks
What is the biggest Cardiovascular outcome trial done with T2D patients?
a) EmpaReg
b) Declare
c) Canvas
b) The Declare trial had as many patients as Canvas and EmpaReg combined
What percentage of Type 2 Diabetics in Canada are considered primary prevention patients
a) 50%
b) 60%
c) 75%
d) 82%
d) 82% 8/10 patients do not yet have established cardiovascular disease.
Using >_____ canisters of SABA a month is associated with an increased mortality?
a) 7
b) 3
c) 1
d) 5
b) 3
demonstrate how to correctly use the Symbicort turbuhaler.
Points awarded for correct demonstration.
Forxiga is the most studied SGLT2 with evidence in the broadest group of patients of any SGLT2s and its totality of evidence spans the cardiorenal continuum. Can you name 3 landmark trials with Forxiga?
Declare, Dapa HF and Dapa CKD
Which SGLT2 fixed dose combination is the most prescribed in Canada?
Xigduo
After 3 months, over 50% of patients have stopped maintenance therapy. After a year adherence decreased to below____%
a)20%
b) 30%
c) 50%
d) 10%
20%
How long does it take for Symbicort to begin to provide relief?
1-3 minutes
What is the only drug indicated to provide cardiovascular protection in this patient?
PatientProfile: A1C 8 / kidneys function / No signs of Cardiovascular disease / high blood pressure /
a) Januvia
b) Forxiga
c) Invokana
d) Jardiance
b) Forxiga - Based on the Declare trial that studied many primary prevention patients
What is the most prescribed SGLT2 by Canadian Cardiologists?
Forxiga